Media » Dr Gottfried Hirnschall, Director of Department of HIV and Global Hepatitis Programme, World Health Organization

Dr Gottfried Hirnschall, Director of Department of HIV and Global Hepatitis Programme, World Health Organization

The new agreement [licence agreement on hepatitis C treatment glecaprevir/pibrentasvir] is an important step towards achieving elimination of hepatitis C worldwide. We urge national governments to take action now to make such curative treatments available for the millions of people in need.

Dr Gottfried Hirnschall, Director of Department of HIV and Global Hepatitis Programme, World Health Organization
This website uses cookies to ensure you get the best experience on our website. Learn More